Kahler, K.C., & Hauschild, A. (2011). Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma. Journal of the German Society of Dermatology, 9, 277–286.
RESOURCE TYPE: Expert opinion
PHASE OF CARE: Active antitumor treatment
N/A
Expert opinion level information
Currently, limited research evidence regarding interventions for the prevention and management of various side effects associated with immunotherapies exists. Corticosteroids are suggested to treat most side effects.